Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01793168
Recruitment Status : Recruiting
First Posted : February 15, 2013
Last Update Posted : March 6, 2019
Sponsor:
Collaborators:
National Ataxia Foundation
International WAGR Syndrome Association
4p- Support Group
ML4 Foundation
Cornelia de Lange Syndrome Foundation
Stickler Involved People
Kawasaki Disease Foundation
Klippel-Feil Syndrome Alliance
Klippel-Feil Syndrome Freedom
Hyperacusis Research Limited
Hypersomnia Foundation
Kabuki Syndrome Network
Kleine-Levin Syndrome Foundation
Leiomyosarcoma Direct Research Foundation
Marinesco-Sjogren Syndrome Support Group - NORD
Mucolipidosis Type IV (ML4) Foundation
People with Narcolepsy 4 People with Narcolepsy (PWN4PWN)
Soft Bones Incorporated
American Multiple Endocrine Neoplasia Support
Atypical Hemolytic Uremic Syndrome Foundation
All Things Kabuki
Wiedemann-Steiner Syndrome Foundation
Breast Implant Victim Advocates
PROS Foundation
American Behcet's Disease Association
Information provided by (Responsible Party):
Sanford Health

Tracking Information
First Submitted Date February 13, 2013
First Posted Date February 15, 2013
Last Update Posted Date March 6, 2019
Actual Study Start Date July 2010
Estimated Primary Completion Date December 2100   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: February 13, 2013)		 To accelerate research into rare disorders by connecting individuals who are interested in research and who have been diagnosed with a rare disorder (or a disorder of unknown prevalence, or who are undiagnosed) with researchers who study rare diseases. [ Time Frame: 100 years ]
Original Primary Outcome Measures Same as current
Change History Complete list of historical versions of study NCT01793168 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Official Title Coordination of Rare Diseases at Sanford
Brief Summary CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access. Visit sanfordresearch.org/CoRDS to enroll.
Detailed Description

CoRDS collects contact, sociodemographic and health information about participants. This information is entered into CoRDS and linked to a unique coded identifier. Below are some examples of information requested on the Questionnaire that will be entered into CoRDS:

  • Contact information: Name, Mailing Address, Phone Number, Email Address
  • Sociodemographic information: Date of Birth, Place of Birth, Sex, Gender, Ethnicity
  • Health information: Family History, Information related to Diagnosis

De-identified information in CoRDS will be made available to researchers, if they have obtained approval for their research project from (1) the Institutional Review Board (IRB) at the researcher's institution and (2) a panel of experts.

A subset of de-identified information collected from each profile may be shared with certain other databases. This is done in order to help improve understanding of rare diseases, to avoid the duplication of efforts and to collaborate with existing research efforts with organizations dedicated to rare diseases.

Participants may elect to have their information shared with patient advocacy groups (PAGs) representing individuals with rare or uncommon diseases who have partnered with CoRDS. The PAG will sign an agreement stating that they will not use the information for Research purposes. CoRDS personnel will not be held responsible for the use of information by the PAG.

The CoRDS Registry will not be paid by Researchers, Other Patient Registries or Patient Advocacy Groups (PAGs) for access to information in CoRDS.

If a parent/LAR consents on behalf of a minor, CoRDS will contact the participant when he or she reaches the age of 18 in order to obtain consent. If this consent is not obtained in a timely manner, the participant will be withdrawn from CoRDS.

CoRDS contacts participants annually to confirm continued interest in participation in CoRDS, and to request that participants update the information they have provided.
Study Type Observational [Patient Registry]
Study Design Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration 100 Years
Biospecimen Retention:   None Retained
Description:
Biospecimen collection capability anticipated in 2014.
Sampling Method Non-Probability Sample
Study Population Unaffected carriers, undiagnosed and those with a rare disease or rare condition.
Condition
  • Rare Disorders
  • Undiagnosed Disorders
  • Disorders of Unknown Prevalence
  • Cornelia De Lange Syndrome
  • Prenatal Benign Hypophosphatasia
  • Perinatal Lethal Hypophosphatasia
  • Odontohypophosphatasia
  • Adult Hypophosphatasia
  • Childhood-onset Hypophosphatasia
  • Infantile Hypophosphatasia
  • Hypophosphatasia
  • Kabuki Syndrome
  • Bohring-Opitz Syndrome
  • Narcolepsy Without Cataplexy
  • Narcolepsy-cataplexy
  • Hypersomnolence Disorder
  • Idiopathic Hypersomnia Without Long Sleep Time
  • Idiopathic Hypersomnia With Long Sleep Time
  • Idiopathic Hypersomnia
  • Kleine-Levin Syndrome
  • Kawasaki Disease
  • Leiomyosarcoma
  • Leiomyosarcoma of the Corpus Uteri
  • Leiomyosarcoma of the Cervix Uteri
  • Leiomyosarcoma of Small Intestine
  • Acquired Myasthenia Gravis
  • Addison Disease
  • Hyperacusis (Hyperacousis)
  • Juvenile Myasthenia Gravis
  • Transient Neonatal Myasthenia Gravis
  • Williams Syndrome
  • Lyme Disease
  • Myasthenia Gravis
  • Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome)
  • Isolated Klippel-Feil Syndrome
  • Frasier Syndrome
  • Denys-Drash Syndrome
  • Beckwith-Wiedemann Syndrome
  • Emanuel Syndrome
  • Isolated Aniridia
  • Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11
  • Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15
  • Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion
  • Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication
  • Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion
  • Axenfeld-Rieger Syndrome
  • Aniridia-intellectual Disability Syndrome
  • Aniridia - Renal Agenesis - Psychomotor Retardation
  • Aniridia - Ptosis - Intellectual Disability - Familial Obesity
  • Aniridia - Cerebellar Ataxia - Intellectual Disability
  • Aniridia - Absent Patella
  • Aniridia
  • Peters Anomaly - Cataract
  • Peters Anomaly
  • Potocki-Shaffer Syndrome
  • Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11
  • Silver-Russell Syndrome Due to Imprinting Defect of 11p15
  • Silver-Russell Syndrome Due to 11p15 Microduplication
  • Syndromic Aniridia
  • WAGR Syndrome
  • Wolf-Hirschhorn Syndrome
  • 4p16.3 Microduplication Syndrome
  • 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome
  • Autosomal Recessive Stickler Syndrome
  • Stickler Syndrome Type 2
  • Stickler Syndrome Type 1
  • Stickler Syndrome
  • Mucolipidosis Type 4
  • X-linked Spinocerebellar Ataxia Type 4
  • X-linked Spinocerebellar Ataxia Type 3
  • X-linked Intellectual Disability - Ataxia - Apraxia
  • X-linked Progressive Cerebellar Ataxia
  • X-linked Non Progressive Cerebellar Ataxia
  • X-linked Cerebellar Ataxia
  • Vitamin B12 Deficiency Ataxia
  • Toxic Exposure Ataxia
  • Unclassified Autosomal Dominant Spinocerebellar Ataxia
  • Thyroid Antibody Ataxia
  • Sporadic Adult-onset Ataxia of Unknown Etiology
  • Spinocerebellar Ataxia With Oculomotor Anomaly
  • Spinocerebellar Ataxia With Epilepsy
  • Spinocerebellar Ataxia With Axonal Neuropathy Type 2
  • Spinocerebellar Ataxia Type 8
  • Spinocerebellar Ataxia Type 7
  • Spinocerebellar Ataxia Type 6
  • Spinocerebellar Ataxia Type 5
  • Spinocerebellar Ataxia Type 4
  • Spinocerebellar Ataxia Type 37
  • Spinocerebellar Ataxia Type 36
  • Spinocerebellar Ataxia Type 35
  • Spinocerebellar Ataxia Type 34
  • Spinocerebellar Ataxia Type 32
  • Spinocerebellar Ataxia Type 31
  • Spinocerebellar Ataxia Type 30
  • Spinocerebellar Ataxia Type 3
  • Spinocerebellar Ataxia Type 29
  • Spinocerebellar Ataxia Type 28
  • Spinocerebellar Ataxia Type 27
  • Spinocerebellar Ataxia Type 26
  • Spinocerebellar Ataxia Type 25
  • Spinocerebellar Ataxia Type 23
  • Spinocerebellar Ataxia Type 22
  • Spinocerebellar Ataxia Type 21
  • Spinocerebellar Ataxia Type 20
  • Spinocerebellar Ataxia Type 2
  • Spinocerebellar Ataxia Type 19/22
  • Spinocerebellar Ataxia Type 18
  • Spinocerebellar Ataxia Type 17
  • Spinocerebellar Ataxia Type 16
  • Spinocerebellar Ataxia Type 15/16
  • Spinocerebellar Ataxia Type 14
  • Spinocerebellar Ataxia Type 13
  • Spinocerebellar Ataxia Type 12
  • Spinocerebellar Ataxia Type 11
  • Spinocerebellar Ataxia Type 10
  • Spinocerebellar Ataxia Type 1 With Axonal Neuropathy
  • Spinocerebellar Ataxia Type 1
  • Spinocerebellar Ataxia - Unknown
  • Spinocerebellar Ataxia - Dysmorphism
  • Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature
  • Spectrin-associated Autosomal Recessive Cerebellar Ataxia
  • Spasticity-ataxia-gait Anomalies Syndrome
  • Spastic Ataxia With Congenital Miosis
  • Spastic Ataxia - Corneal Dystrophy
  • Spastic Ataxia
  • Rare Hereditary Ataxia
  • Rare Ataxia
  • Recessive Mitochondrial Ataxia Syndrome
  • Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature
  • Posterior Column Ataxia - Retinitis Pigmentosa
  • Post-Stroke Ataxia
  • Post-Head Injury Ataxia
  • Post Vaccination Ataxia
  • Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract
  • Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus
  • Non-progressive Cerebellar Ataxia With Intellectual Disability
  • Non-hereditary Degenerative Ataxia
  • Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity
  • Olivopontocerebellar Atrophy - Deafness
  • NARP Syndrome
  • Myoclonus - Cerebellar Ataxia - Deafness
  • Multiple System Atrophy, Parkinsonian Type
  • Multiple System Atrophy, Cerebellar Type
  • Multiple System Atrophy
  • Maternally-inherited Leigh Syndrome
  • Machado-Joseph Disease Type 3
  • Machado-Joseph Disease Type 2
  • Machado-Joseph Disease Type 1
  • Lethal Ataxia With Deafness and Optic Atrophy
  • Leigh Syndrome
  • Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema
  • Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination
  • Leigh Syndrome With Nephrotic Syndrome
  • Leigh Syndrome With Leukodystrophy
  • Leigh Syndrome With Cardiomyopathy
  • Late-onset Ataxia With Dementia
  • Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome
  • Infection or Post Infection Ataxia
  • Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia
  • Infantile Onset Spinocerebellar Ataxia
  • GAD Ataxia
  • Hereditary Episodic Ataxia
  • Gliadin/Gluten Ataxia
  • Friedreich Ataxia
  • Fragile X-associated Tremor/Ataxia Syndrome
  • Familial Paroxysmal Ataxia
  • Exposure to Medications Ataxia
  • Episodic Ataxia With Slurred Speech
  • Episodic Ataxia Unknown Type
  • Episodic Ataxia Type 7
  • Episodic Ataxia Type 6
  • Episodic Ataxia Type 5
  • Episodic Ataxia Type 4
  • Episodic Ataxia Type 3
  • Episodic Ataxia Type 1
  • Epilepsy and/or Ataxia With Myoclonus as Major Feature
  • Early-onset Spastic Ataxia-neuropathy Syndrome
  • Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity
  • Early-onset Cerebellar Ataxia With Retained Tendon Reflexes
  • Early-onset Ataxia With Dementia
  • Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia
  • Dilated Cardiomyopathy With Ataxia
  • Cataract - Ataxia - Deafness
  • Cerebellar Ataxia, Cayman Type
  • Cerebellar Ataxia With Peripheral Neuropathy
  • Cerebellar Ataxia - Hypogonadism
  • Cerebellar Ataxia - Ectodermal Dysplasia
  • Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss
  • Brain Tumor Ataxia
  • Brachydactyly - Nystagmus - Cerebellar Ataxia
  • Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia
  • Autosomal Recessive Syndromic Cerebellar Ataxia
  • Autosomal Recessive Spastic Ataxia With Leukoencephalopathy
  • Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
  • Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria
  • Autosomal Recessive Spastic Ataxia
  • Autosomal Recessive Metabolic Cerebellar Ataxia
  • Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine
  • Autosomal Recessive Ataxia, Beauce Type
  • Autosomal Recessive Ataxia Due to Ubiquinone Deficiency
  • Autosomal Recessive Ataxia Due to PEX10 Deficiency
  • Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia
  • Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency
  • Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency
  • Autosomal Recessive Congenital Cerebellar Ataxia
  • Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome
  • Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency
  • Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency
  • Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency
  • Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome
  • Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity
  • Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency
  • Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect
  • Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion
  • Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation
  • Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness
  • Autosomal Recessive Cerebellar Ataxia
  • Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly
  • Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation
  • Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy
  • Autosomal Dominant Spastic Ataxia Type 1
  • Autosomal Dominant Spastic Ataxia
  • Autosomal Dominant Optic Atrophy
  • Ataxia-telangiectasia Variant
  • Ataxia-telangiectasia
  • Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy
  • Autosomal Dominant Cerebellar Ataxia Type 4
  • Autosomal Dominant Cerebellar Ataxia Type 3
  • Autosomal Dominant Cerebellar Ataxia Type 2
  • Autosomal Dominant Cerebellar Ataxia Type 1
  • Autosomal Dominant Cerebellar Ataxia
  • Ataxia-telangiectasia-like Disorder
  • Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome
  • Ataxia-deafness-intellectual Disability Syndrome
  • Ataxia With Vitamin E Deficiency
  • Ataxia With Dementia
  • Ataxia Neuropathy Spectrum
  • Ataxia - Tapetoretinal Degeneration
  • Ataxia - Photosensitivity - Short Stature
  • Ataxia - Pancytopenia
  • Ataxia - Oculomotor Apraxia Type 1
  • Ataxia - Hypogonadism - Choroidal Dystrophy
  • Ataxia - Other
  • Ataxia - Genetic Diagnosis - Unknown
  • Acquired Ataxia
  • Adult-onset Autosomal Recessive Cerebellar Ataxia
  • Alcohol Related Ataxia
  • Multiple Endocrine Neoplasia
  • Multiple Endocrine Neoplasia Type II
  • Multiple Endocrine Neoplasia Type 1
  • Multiple Endocrine Neoplasia Type 2
  • Multiple Endocrine Neoplasia, Type IV
  • Multiple Endocrine Neoplasia, Type 3
  • Multiple Endocrine Neoplasia (MEN) Syndrome
  • Multiple Endocrine Neoplasia Type 2B
  • Multiple Endocrine Neoplasia Type 2A
  • Atypical Hemolytic Uremic Syndrome
  • Atypical HUS
  • Wiedemann-Steiner Syndrome
  • Breast Implant-Associated Anaplastic Large Cell Lymphoma
  • Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)
  • Hemophagocytic Lymphohistiocytosis
  • Behcet's Disease
  • Alagille Syndrome
  • Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)
  • Lowe Syndrome
  • Pitt Hopkins Syndrome
  • 1p36 Deletion Syndrome
  • Jansen Type Metaphyseal Chondrodysplasia
  • Cockayne Syndrome
  • Chronic Recurrent Multifocal Osteomyelitis
  • CRMO
  • Malan Syndrome
  • Hereditary Sensory and Autonomic Neuropathy Type Ie
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: September 28, 2017)		 20000
Original Estimated Enrollment
 (submitted: February 13, 2013)		 1000
Estimated Study Completion Date December 2100
Estimated Primary Completion Date December 2100   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Diagnosis of a rare disease, a disease of unknown prevalence, undiagnosed or an unaffected carrier of a rare/uncommon disease

Exclusion Criteria:

  • Diagnosis of a disease which is not rare
Sex/Gender
Sexes Eligible for Study: All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts
Contact: CoRDS Team 1-877-658-9192 cords@sanfordhealth.org
Listed Location Countries Australia,   United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT01793168
Other Study ID Numbers 03-10-014
Hypersomnia Foundation ( Registry Identifier: Hypersomnia Registry )
National Ataxia Foundation ( Registry Identifier: Ataxia Registry )
4p- Support Group ( Registry Identifier: 4p-/Wolfhirschhorn Syndrome Registry )
CdLS Foundation ( Registry Identifier: Cornelia de Lange Syndrome Registry )
Hyperacusis Research Limited ( Registry Identifier: Hyperacusis Registry )
Kabuki Syndrome Network ( Registry Identifier: Kabuki Syndrome Registry )
Kawasaki Disease Foundation ( Registry Identifier: Kawasaki Disease Registry )
Klippel-Feil Syndrome Freedom ( Registry Identifier: Klippel-Feil Syndrome Registry )
Leiomyosarcoma Direct Research ( Registry Identifier: Leiomyosarcoma Registry )
MSS Support Group ( Registry Identifier: Marinesco-Sjogren Syndrome Registry )
ML4 Foundation ( Registry Identifier: Mucolipidosis Type IV (ML4) Registry )
Stickler Involved People ( Registry Identifier: Stickler Syndrome Registry )
IWSA ( Registry Identifier: WAGR Syndrome Registry )
Soft Bones ( Registry Identifier: Hypophosphatasia Registry )
PWN4PWN ( Registry Identifier: Narcolepsy Registry )
aHUS ( Registry Identifier: aHUS Registry )
Klippel-Feil Syndrome Alliance ( Registry Identifier: KFS Registry )
American MEN Support ( Registry Identifier: Mulitiple Endocrine Neoplasia Registry )
Kleine-Levin Syndrome ( Registry Identifier: Kleine-Levin Syndrome Registry )
All Things Kabuki ( Registry Identifier: Kabuki Syndrome Registry )
WSS Foundation ( Registry Identifier: Wiedemann-Steiner Syndrome Registry )
BIVA ( Registry Identifier: Brest Implant-Associated ALCL Registry )
ABDA ( Registry Identifier: American Bechet's Disease Association Registry )
PROS Foundation (HLH) ( Registry Identifier: Hemophagocytic Lymphohistiocytosis (HLH) Registry )
Alagille Syndrome Association ( Registry Identifier: Alagillle Syndrome Registry )
Cure VCP Disease, Inc. ( Registry Identifier: IBMPFD Registry )
Lowe Syndrome Association ( Registry Identifier: Lowe Syndrome Registry )
Pitt Hopkins ( Registry Identifier: Pitt Hopkins Registry )
Cure Batten Disease ( Registry Identifier: Batten Disease Registry )
Hypnic Jerk/Sleep Myoclonus ( Registry Identifier: Hypnic Jerk/Sleep Myoclonus Registry )
1p36 DSA ( Registry Identifier: 1p36 Deletion Syndrome Registry )
Jansen Foundation ( Registry Identifier: The Jansen Foundation Registry )
Share and Care Network ( Registry Identifier: Cockayne Syndrome Registry )
CRMO ( Registry Identifier: CRMO Registry )
The Malan Syndrome Foundation ( Registry Identifier: Malan Syndrome Registry )
HSAN1E Society ( Registry Identifier: HSAN1E Registry )
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement
Plan to Share IPD: Yes
Plan Description: Deidentified participant data is shared with contracted patient advocacy groups for non-research purposes. Parties interested in accessing data are welcome to apply (cost-free) at http://www.sanfordresearch.org/cords/researchers/.
Responsible Party Sanford Health
Study Sponsor Sanford Health
Collaborators
  • National Ataxia Foundation
  • International WAGR Syndrome Association
  • 4p- Support Group
  • ML4 Foundation
  • Cornelia de Lange Syndrome Foundation
  • Stickler Involved People
  • Kawasaki Disease Foundation
  • Klippel-Feil Syndrome Alliance
  • Klippel-Feil Syndrome Freedom
  • Hyperacusis Research Limited
  • Hypersomnia Foundation
  • Kabuki Syndrome Network
  • Kleine-Levin Syndrome Foundation
  • Leiomyosarcoma Direct Research Foundation
  • Marinesco-Sjogren Syndrome Support Group - NORD
  • Mucolipidosis Type IV (ML4) Foundation
  • People with Narcolepsy 4 People with Narcolepsy (PWN4PWN)
  • Soft Bones Incorporated
  • American Multiple Endocrine Neoplasia Support
  • Atypical Hemolytic Uremic Syndrome Foundation
  • All Things Kabuki
  • Wiedemann-Steiner Syndrome Foundation
  • Breast Implant Victim Advocates
  • PROS Foundation
  • American Behcet's Disease Association
Investigators Not Provided
PRS Account Sanford Health
Verification Date March 2019